Sirdalud MR 6 mg - Kapseln (parallel import Orifarm GmbH)

Recall | Medicines | 12/07/2023

The parallel distributor and marketing authorisation holder informed its customers on July 12, 2023, that the active ingredient release in the mentioned batches may lie outside the specified limits. This could affect its effectiveness. Therefore, this batch will be recalled as precaution.

Name of the medicinal product Sirdalud MR 6 mg - Kapseln
Marketing authorisation number(s) 1-19584-P1
CIP code 4977186
Marketing authorisation holder Orifarm GmbH
Batch number(s) KCA71, KCA72
Expiry date 02/29/2024
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-4387

Further inquiry note